ImmunoTek Bio Centers

What ImmunoTek Bio Centers does

ImmunoTek Bio Centers, LLC is a privately held US biotech operating company founded on July 18, 2013 by Jerome Parnell III and headquartered in Southlake, Texas. It is the self-described world's largest and fastest-growing independent blood plasma collection company, operating approximately 45 plasma donation centers across 21 states through two sub-brands: the wholly-owned ImmunoTek Plasma network and the co-developed Freedom Plasma network, which it operates in partnership with a global healthcare company and leading manufacturer of plasma-derived medicines. Across its first decade, the company has accepted more than 7 million paid donations and developed more than 80 centers for biopharmaceutical partners.

The company's core service is automated plasmapheresis — a sterile, single-use process that separates plasma from whole blood and returns remaining components to the donor, allowing donations up to twice per week. Donor screening is supported by Haemonetics-powered biometric fingerprint authentication that produces a numerical electronic signature stored in the donor profile, and needle insertion is aided by Christie Medical Holdings' VeinViewer real-time vein illumination technology, in which ImmunoTek is the first plasma collection operator to deploy. Donors are compensated via a prepaid debit card, and the iTek Referral Network pays $50 per successfully referred second-time donor.

ImmunoTek's commercial model is hybrid B2B/B2C. On the supply side, it acquires raw material (plasma) from a long tail of individual donors compensated per donation. On the demand side, it sells that plasma to biopharmaceutical manufacturers under supply agreements for fractionation into plasma-derived therapies (immunoglobulins, clotting factors, albumin, alpha-1 antitrypsin) used in immune deficiencies, bleeding disorders, burns, trauma, and rare diseases. Revenue mechanics are transactional per liter of plasma supplied. Most centers hold or are pursuing US FDA licensure and European certification, and the CEO sits on the PPTA Global Source Board of Directors, giving the firm meaningful influence over industry sourcing standards.

Name

ImmunoTek Bio Centers

Legal name

ImmunoTek Bio Centers, LLC

Website

https://immunotek.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

251–500 employees

Short description

ImmunoTek Bio Centers operates the world's largest independent network of US plasma donation centers, collecting source plasma from compensated donors and supplying it to biopharmaceutical manufacturers for fractionation into plasma-derived therapies.

Ownership category

akta.pro rank

Product category

Plasma Collection Services

NAICS

Blood and Organ Banks (621991), Biological Product (except Diagnostic) Manufacturing (325414), Medical Laboratories (621511)

SIC

Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)

akta.pro secondary industries

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG), Immunoglobulins & Passive Immunization Biologics (IVIG, hyperimmune globulins, antitoxins) (HLAAAEAH)

Keywords

• Plasma collection services
• Blood plasma donation
• Plasmapheresis operations
• Biopharmaceutical plasma supply
• Plasma donation centers

Headquarters

HQ city

Southlake

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Plasma Collection Services: ImmunoTek collects plasma from paid donors at its collection centers and supplies the plasma to biopharmaceutical companies for manufacturing plasma-based therapies. The company generates revenue through payments from biotech partners for plasma supply.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

ImmunoTek Bio Centers operates a nationwide network of FDA-licensed plasma donation centers under two brands, ImmunoTek Plasma and Freedom Plasma. It collects source plasma from compensated individual donors via automated plasmapheresis and supplies that plasma to biopharmaceutical manufacturers for use in plasma-derived therapies. Donors are screened, identified via biometric fingerprint authentication, and compensated through a pre-paid debit card.

Product overview

ImmunoTek Bio Centers operates a network of plasma donation centers under two sub-brands: ImmunoTek Plasma (the primary brand) and Freedom Plasma (operated in partnership with a global healthcare company). The company's core service is plasmapheresis collection — a sterile, automated process that separates plasma from donor blood and returns remaining components. Donors are compensated via a pre-paid debit card. Supporting programs include a referral network that rewards donors $50 per successful referral, and biometric donor identification using fingerprint scanning technology powered by Haemonetics. The company celebrated its 10th anniversary in July 2023 and operates approximately 45 centers across 21 states through its two subsidiaries.

Differentiator

Problem solved

Functional benefit

Products and services

• Plasmapheresis Collection Services Automated, sterile, self-contained plasmapheresis process that separates plasma from donor whole blood and returns the remaining components to the donor, performed at ImmunoTek and Freedom Plasma donation centers across the United States for healthy adult donors aged 18-65.
• ImmunoTek Plasma Center Operations Company-owned plasma donation centers operating under the ImmunoTek Plasma brand, providing donor screening, plasmapheresis collection, and donor compensation across multiple U.S. states.
• Freedom Plasma Center Operations Plasma donation centers operated by ImmunoTek in partnership with a global healthcare company and plasma-derived-medicine manufacturer, compensating donors and contributing to the global plasma supply chain.
• B2B Plasma Supply to Biopharmaceutical Manufacturers Long-term supply of FDA-licensed source plasma collected at ImmunoTek and Freedom Plasma centers to global biopharmaceutical companies for manufacturing plasma-based therapies treating rare diseases, immune deficiencies, bleeding disorders, burns, surgical trauma, and shock.
• VeinViewer-Assisted Donor Experience Plasmapheresis collection enhanced by Christie Medical Holdings' VeinViewer direct-projection vein illumination, which displays real-time images of donor veins on the skin before needle insertion to increase accuracy and reduce reinsertions.

Quantifiable outcome

• More than 7 million paid donations accepted since 2013
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Plasma Protein Therapeutics Association (PPTA)minorOthers · 1 June 2022Jerome Parnell III, CEO and President of ImmunoTek Bio Centers, was elected to serve on the PPTA Global Source Board of Directors. PPTA represents blood-plasma collection centers and manufacturers of lifesaving protein therapies made from plasma, working to support access and affordability of plasma-based therapies.
• Global Healthcare Company (Freedom Plasma Partner)coreStrategic or Co-development Partner · 20 May 2022Freedom Plasma was developed and is managed by ImmunoTek Bio Centers in partnership with a global healthcare company and leading manufacturer of plasma-derived medicines. This partnership enables Freedom Plasma to offer donors compensation while contributing to the global plasma supply chain.
• Haemonetics CorporationcoreTechnology or IntegrationImmunoTek uses Haemonetics software and database service for fingerprint scan donor authentication as part of the automated plasmapheresis program and donor screening process. The finger scanner biometric data is stored in Haemonetics' database as part of the software service.

Scale indicators9 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• CSL Plasma: CSL Plasma is the plasma collection arm of CSL Behring and operates one of the largest global networks of plasma collection centers. It is the most directly comparable peer to ImmunoTek — both operate paid donor centers in the U.S. and supply source plasma to biopharmaceutical manufacturers for fractionation into plasma-derived therapies.
• Grifols: Grifols is a vertically integrated global biopharmaceutical company that operates its own plasma collection network (including acquired centers from Biotest and others) and fractionates plasma into therapies. It directly competes with ImmunoTek in U.S. plasma collection and is also one of ImmunoTek's potential B2B buyers.
• BioLife Plasma Services: BioLife Plasma Services is the U.S. plasma collection subsidiary of Takeda Pharmaceutical Company, operating hundreds of paid donor centers across the U.S. Like ImmunoTek, it supplies source plasma to its parent for fractionation, but operates as an integrated player with greater capital backing and a comparable donor experience model.
• Octapharma Plasma: Octapharma Plasma operates more than 150 donation centers across the U.S. and is part of Octapharma AG, a global manufacturer of plasma-derived medicines. It competes directly with ImmunoTek for paid donors and represents both a comparable operator and a potential B2B customer relationship.
• Kedrion Biopharma: Kedrion is an Italy-headquartered biopharmaceutical company that collects plasma and manufactures plasma-derived therapies, with growing U.S. collection operations. It is comparable to ImmunoTek as a plasma collector and a potential strategic partner for center development.
• BPL Plasma: BPL Plasma operates a network of plasma donation centers across the U.S. and is associated with Bio Products Laboratory, a manufacturer of plasma-derived therapies. It directly competes with ImmunoTek for paid donors in overlapping U.S. geographies.

Broad incumbents

• ADMA Biologics: ADMA Biologics is a U.S. biopharmaceutical company that manufactures plasma-derived therapies and is expanding its own vertical supply chain. While not a center operator at ImmunoTek's scale, it is a relevant comparable as a U.S.-based plasma end-buyer and increasingly integrated competitor.
• Takeda Pharmaceutical Company: Takeda owns BioLife Plasma Services, the parent of ImmunoTek's largest direct competitor, and is a major global buyer and fractionator of plasma. It is comparable as a vertically integrated incumbent shaping competitive dynamics and contract pricing in the U.S. source plasma market.

Regional players

• Sanquin Plasma Products: Sanquin is the Dutch national blood and plasma collection organization, operating plasma collection centers primarily in the Netherlands and Europe. It is comparable to ImmunoTek in operating paid/unpaid donor collection networks and supplying plasma to fractionators, but in a different geography and nonprofit structure.

Others

• Haemonetics Corporation: Haemonetics is a medical technology company that supplies plasmapheresis equipment and software (including the biometric donor authentication system used by ImmunoTek). It is comparable as an enabling technology partner in the plasma collection value chain rather than a direct competitor.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key highlights7 records

Customer concentration

• Xx.com/ImmunoTek1
• Facebookfacebook.com/ImmunoTekBioCenters
• LinkedInlinkedin.com/company/immunotek-bio-centers-llc
• Instagraminstagram.com/immunotekbiocenters
• TikToktiktok.com/@immunotek

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ImmunoTek Bio Centers